A multi-center, open-label, randomized phase III trial of first-line chemotherapy with capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancer-Reference-Cited by-同舟云学术

A multi-center, open-label, randomized phase III trial of first-line chemotherapy with capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancer

Published:2017-05 Issue:3 Volume:8 Page:170-175
ISSN:1879-4068
Container-title:Journal of Geriatric Oncology
language:en
Short-container-title:Journal of Geriatric Oncology

Author:

Hwang In Gyu,Ji Jun Ho,Kang Jung Hun,Lee Hyo Rak,Lee Hui-Young,Chi Kyong-Choun,Park Suk Won,Lee Su Jin,Kim Seung Tae,Lee Jeeyun,Park Se Hoon,Park Joon Oh,Park Young Suk,Lim Ho Yeong,Kang Won Ki

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Oncology

Reference19 articles.

1. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data;Wagner;J Clin Oncol,2006

2. Disparities in gastric cancer chemotherapy between the East and West;Ohtsu;J Clin Oncol,2006

3. Chemotherapy of lung cancer in the elderly;Frasci;Crit Rev Oncol Hematol,2002

4. Older age–not a barrier to cancer treatment;Muss;N Engl J Med,2001

5. Gastric cancer epidemiology in Korea;Shin;J Gastric Cancer,2011

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023;Cancer Communications;2023-12-31

2. State of the scientific evidence and recommendations for the management of older patients with gastric cancer;Journal of Geriatric Oncology;2023-11

3. Association of Single-Nucleotide Polymorphisms in Capecitabine Bioactivation Pathway with Adjuvant Therapy Safety in Colorectal Cancer Patients;Pharmaceutics;2023-10-28

4. A Phase 3 Randomized Clinical Trial to Compare Efficacy and Safety between Combination Therapy and Monotherapy in Elderly Patients with Advanced Gastric Cancer (KCSG ST13-10);Cancer Research and Treatment;2023-10-15

5. Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study;Gastric Cancer;2023-08-23